These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2791177)

  • 21. [Use of halothane in a semi-closed circuit].
    Gauneau P; Alfonsi P; Duvaldestin P; Guirimand F; Chauvin M
    Ann Fr Anesth Reanim; 1989; 8(5):493-6. PubMed ID: 2627045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of the Dräger Primus anesthetic machine for malignant hyperthermia-susceptible patients.
    Prinzhausen H; Crawford MW; O'Rourke J; Petroz GC
    Can J Anaesth; 2006 Sep; 53(9):885-90. PubMed ID: 16960266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ambient air contamination in a dental outpatient theatre.
    Thompson JM; Barratt RS; Hutton P; Robinson JS; Belcher R; Stephen WI
    Br J Anaesth; 1979 Sep; 51(9):845-55. PubMed ID: 508490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of the Dräger Fabius anesthesia machine for the malignant-hyperthermia susceptible patient.
    Gunter JB; Ball J; Than-Win S
    Anesth Analg; 2008 Dec; 107(6):1936-45. PubMed ID: 19020141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Administration of halothane in the 0-0.5 per cent concentration range with the Fluotec Mark 2 and Mark 3 vaporizers.
    Latto IP
    Br J Anaesth; 1973 Jun; 45(6):563-9. PubMed ID: 4718247
    [No Abstract]   [Full Text] [Related]  

  • 26. Contamination of in-series vaporizers with halothane-methoxyflurane.
    Murray WJ; Zsigmond EK; Fleming P
    Anesthesiology; 1973 May; 38(5):487-90. PubMed ID: 4709094
    [No Abstract]   [Full Text] [Related]  

  • 27. Accuracy of isoflurane delivery by halothane-specific vaporizers.
    Steffey EP; Woliner MJ; Howland D
    Am J Vet Res; 1983 Jun; 44(6):1072-8. PubMed ID: 6870010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: when are they really clean?
    Wappler F
    Anesthesiology; 2011 Aug; 115(2):434-5; author reply 436-7. PubMed ID: 21791992
    [No Abstract]   [Full Text] [Related]  

  • 29. The oxygen and volatile anaesthetic delivery characteristics during spontaneous ventilation using a non-rebreathing coaxial anaesthesia system.
    Day SK
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):22-5. PubMed ID: 16401939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of the Dräger Fabius GS workstation for malignant hyperthermia-susceptible patients.
    Whitty RJ; Wong GK; Petroz GC; Pehora C; Crawford MW
    Can J Anaesth; 2009 Jul; 56(7):497-501. PubMed ID: 19399571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is your vaporizer off?
    Cook TL; Eger EI; Behl RS
    Anesth Analg; 1977; 56(6):793-800. PubMed ID: 563184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice.
    Kim TW; Nemergut ME
    Anesthesiology; 2011 Jan; 114(1):205-12. PubMed ID: 21169802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Room air contamination with halothane during pediatric bronchoscopy].
    Hoerauf K; Kessler P; Alemdag Y; Wiesner G; Janhson G; Taeger K
    Zentralbl Hyg Umweltmed; 1997 Apr; 199(6):551-7. PubMed ID: 9376067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of theatres for malignant hyperpyrexia patients.
    McKenzie A; Pollock N
    Anaesth Intensive Care; 1989 Nov; 17(4):510-1. PubMed ID: 2596685
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dependence of the inspiratory halothane concentration in a closed system on the level of fresh gas flow].
    Baer B
    Anaesthesist; 1983 Jan; 32(1):6-11. PubMed ID: 6846780
    [No Abstract]   [Full Text] [Related]  

  • 36. Inadvertent change of volatile anesthetics in anesthesia machines.
    Karis JH; Menzel DB
    Anesth Analg; 1982 Jan; 61(1):53-5. PubMed ID: 7198415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of the Siemens KION anesthetic machine for patients susceptible to malignant hyperthermia.
    Petroz GC; Lerman J
    Anesthesiology; 2002 Apr; 96(4):941-6. PubMed ID: 11964603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Measurement of the inspiratory halothane concentration with the halothane meter].
    Langrehr D; Kluge I; Riecken I
    Anaesthesist; 1970 Sep; 19(9):340-5. PubMed ID: 5521632
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: New causes of malignant hyperpyrexia.
    Lack JA
    Br Med J; 1975 Jan; 1(5948):36-7. PubMed ID: 1120228
    [No Abstract]   [Full Text] [Related]  

  • 40. A random survey of anesthesia machines and ancillary monitors in 45 hospitals.
    Kumar V; Hintze MS; Jacob AM
    Anesth Analg; 1988 Jul; 67(7):644-9. PubMed ID: 3382037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.